In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Belden, President of Tjoapack US. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering:  How the success of a contract packaging operation led to a divestiture from AmerisourceBergen to PCI The fun, games, and complexities of multi-national, M&A integrations Smaller patient populations and personalized medicines drive demand for more flexible and agile contract packaging providers Active listening, removing headaches from clients, and eliminating roadblocks are key to success Peter is a leader in pharmaceutical services and is passionate about building teams that delight clients. He recently joined the Tjoapack team as President of, US, to help embark on the next stage of the company’s growth by delivering quality, service, and flexible solutions to clients. With 25 years of service to pharmaceutical and biotech clients across packaging materials, contract packaging for clinical supplies and commercial medicines, specialty third-party logistics, and related commercialization offerings. He has held leadership roles at AmerisourceBergen, Avery Dennison, PCI, and Clinigen Group. Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital, and content agency helping companies differentiate, get noticed and grow in life sciences.